Successful, but ungrounded by an actual mechanism?
Maybe? If so I guess that still beats the drug that was “grounded by a mechanism” but failed to show efficacy and still somehow wound up getting approved by the FDA.
Both this drug (lecanemab) and the drug to which you're referring (aducanumab) are amyloid antibodies